EGLE THERAPEUTICS
Egle Therapeutics is an emerging biotechnology company focused on developing First-In-Class immunotherapies targeting immune suppressor regulatory T-cells (Tregs) for oncology and autoimmune diseases. The company was founded in 2020 and is based in Paris, France.
EGLE THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2020-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.egle-tx.com
Total Employee:
11+
Status:
Active
Contact:
+33-186640857
Email Addresses:
[email protected]
Total Funding:
40 M EUR
Technology used in webpage:
Microsoft Exchange Online
Similar Organizations
Immunscape AB
Immunscape is a privately held drug discovery focused on developing immunotherapies for cancer and autoimmune disease treatment.
Current Advisors List
Current Employees Featured
Founder
Investors List
Fund+
Fund+ investment in Series A - Egle Therapeutics
Takeda Ventures
Takeda Ventures investment in Series A - Egle Therapeutics
Life Sciences Partners
Life Sciences Partners investment in Series A - Egle Therapeutics
Bpifrance
Bpifrance investment in Series A - Egle Therapeutics
Bioqube Ventures
Bioqube Ventures investment in Series A - Egle Therapeutics
Official Site Inspections
http://www.egle-tx.com
- Host name: cluster020.hosting.ovh.net
- IP address: 46.105.57.169
- Location: Saint-Ouen France
- Latitude: 48.9067
- Longitude: 2.3339
- Timezone: Europe/Paris
- Postal: 93400
Loading ... 